Hematein is a oxidation product of hematoxylin acted as a dye. Hematein is an allosteric casein kinase II inhibitor with an IC 50 of 0.74 μM. Hematein inhibits Akt/PKB Ser129 phosphorylation, the Wnt/TCF pathway and increases apoptosis in lung cancer cells.
性状
Solid
IC50 & Target[1][2]
CKII 0.74 μM (IC50)
体外研究(In Vitro)
Hematein (10-100 μM; 14 days) inhibits cells growth in A427 lung cancer cells. Hematein (50 and 100 μM; 48 hours) induces apoptosis in A427 lung cancer cells. Hematein (50 and 100 μM; 48 hours) inhibits CK2-specific Akt phosphorylation. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability Assay-tbl">
体内研究(In Vivo)
Hematein (intraperitoneal injections; 50 mg/kg; twice a week for 6 weeks) inhibits tumor growth in A427 lung cancer cell xenografts. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Shirai, K., & Matsuoka, M. (1996). Structure and properties of hematein derivatives. Dyes and Pigments, 32(3), 159–169.[2]. Hung MS, et al. Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograftmodel.Int J Oncol. 2013 Nov;43(5):1517-22.
溶解度数据
In Vitro: DMSO : 100 mg/mL (333.04 mM; Need ultrasonic)配制储备液